Update: SAP Q2 Non-IFRS EPS Beats But Higher Revenue Misses Expectations; Shares Drop Premarket-February 2024-www.financetom.com

Update: SAP Q2 Non-IFRS EPS Beats But Higher Revenue Misses Expectations; Shares Drop Premarket

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Update: SAP Q2 Non-IFRS EPS Beats But Higher Revenue Misses Expectations; Shares Drop Premarket

Jul 23, 2025 2:47 AM

05:20 AM EDT, 07/23/2025 (MT Newswires) -- (Updates with the recent stock move in the headline and the last paragraph.)

SAP (SAP) reported Q2 non-IFRS earnings Tuesday of 1.50 euros ($1.76) per basic share, up from 1.10 euros a year earlier.

Analysts polled by FactSet expected 1.42 euros.

Revenue for the quarter ended June 30 was 9.03 billion euros, up from 8.29 billion euros a year earlier.

Analysts surveyed by FactSet expected 9.09 billion euros.

The company's US-listed shares were down 3.8% in recent premarket activity Wednesday.

Price: 294.55, Change: -11.58, Percent Change: -3.78

Previous page： Ameren Insider Sold Shares Worth $262,250, According to a Recent SEC Filing Next page： Centessa Pharmaceuticals Insider Sold Shares Worth $1,120,000, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Ameren Insider Sold Shares Worth $262,250, According to a Recent SEC Filing

Nov 18, 2025

04:27 PM EST, 11/18/2025 (MT Newswires) -- Richard J Harshman, Director, on November 14, 2025, sold 2,500 shares in Ameren ( AEE ) for $262,250. Following the Form 4 filing with the SEC, Harshman has control over a total of 20,378 common shares of the company, with 20,378 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1002910/000120024425000005/xslF345X05/wk-form4_1763500630.xml ...

Centessa Pharmaceuticals Insider Sold Shares Worth $1,120,000, According to a Recent SEC Filing

Nov 18, 2025

04:28 PM EST, 11/18/2025 (MT Newswires) -- Tia L Bush, Chief Technology & Quality Officer, on November 17, 2025, sold 40,000 shares in Centessa Pharmaceuticals ( CNTA ) for $1,120,000. Following the Form 4 filing with the SEC, Bush has control over a total of 121,503 ordinary shares of the company, with 121,503 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1847903/000147083125000343/xslF345X05/wk-form4_1763500628.xml ...

Dolby Laboratories Fiscal Q4 Adjusted Earnings, Revenue Rise; Q1 Guidance Set; Dividend Boosted

Nov 18, 2025

04:26 PM EST, 11/18/2025 (MT Newswires) -- Dolby Laboratories ( DLB ) reported fiscal Q4 adjusted earnings late Tuesday of $0.99 per diluted share, up from $0.81 a year earlier. Three analysts polled by FactSet expected $0.70. Revenue for the three months ended Sept. 26 was $307 million, up from $304.8 million a year earlier. Analysts surveyed by FactSet expected...

La-Z-Boy Q2 EPS beats estimates on wholesale segment margin expansion

Nov 18, 2025

Overview * La-Z-Boy ( LZB ) fiscal Q2 sales slightly beat analyst expectations * Adjusted EPS for fiscal Q2 beats analyst expectations * The furniture retailer completed 15-store acquisition, plans to exit non-core businesses Outlook * Company expects fiscal Q3 sales between $525 mln and $545 mln * La-Z-Boy ( LZB ) anticipates Q3 adjusted operating margin of 5.0-6.5% *...